Pharma companies seek US FDA guidelines on social media promotion
This article was originally published in Scrip
Executive Summary
Creating US FDA-approved "safe" websites for drug product information and allowing extensive risk and prescribing information to be accessed by one click through a hyperlink were among the many suggestions that agency staff heard for regulating drug and medical device promotions through the internet and social media.